DiaMed GmbH

Name

DiaMed GmbH

Legal name

Bio-Rad Laboratories, Inc.

Website

https://diamed.com

Company type

Public

Founded year

1957

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Immunohematology Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH)

akta.pro secondary industries

Blood Bank/Transfusion Medicine LIS (HLACAMAE), Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN), Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)

Keywords

• Immunohematology diagnostics
• Blood typing reagents
• Blood transfusion testing
• Clinical quality control
• Laboratory automation instruments

Headquarters

HQ city

Cressier FR

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Immunohematology Instruments and Reagents: Bio-Rad generates revenue from the sale of blood typing instruments (automated and manual), reagents, and consumables for immunohematology testing. The IH-Complete portfolio includes instruments, reagents, connectivity, quality, support, and cybersecurity components sold as integrated or individual products.
2. Quality Control Products and Services: Bio-Rad is the world leader in clinical quality control products, services, and information systems. These products ensure the accuracy and validity of clinical test results and represent a significant revenue stream from clinical diagnostic laboratories.
3. Data Management and Connectivity Software: Software solutions including IH-Com, IH-Web, and IH-AᵇID provide data management and connectivity for immunohematology instruments, generating revenue as part of the integrated IH-Complete solution.
4. Life Science Research and Clinical Diagnostic Products: Beyond immunohematology, Bio-Rad's broader portfolio spans life science research laboratories and clinical diagnostic markets including diabetes monitoring, autoimmune testing, and infectious disease testing, serving as an additional revenue base for the parent company.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

DiaMed GmbH (a Bio-Rad company) provides the IH-Complete integrated immunohematology solution for blood transfusion medicine laboratories. The offering combines blood typing reagents (Gel, Tube, and Microplate formats), automated instruments including the IH-1000 and IH-500 Systems, data management and connectivity software (IH-Com, IH-Web, IH-AᵇID), the Unity quality control program, BRiCare technical support, and a product cybersecurity program. Customers are hospital blood banks, transfusion centers, and clinical diagnostic laboratories performing donor-patient compatibility testing.

Product overview

DiaMed GmbH (a Bio-Rad company) offers the IH-Complete integrated immunohematology solution for blood transfusion medicine laboratories. The platform consists of a comprehensive reagent portfolio (Gel, Tube, and Microplate testing formats including Blood Grouping ABO/D with 22 products, Rh/K Phenotyping with 5 products, Extended Phenotyping with 33 products, Antibody Screening & Identification with 7 products, DAT Testing with 6 products, Titration, Reagent Red Blood Cells with 13 products, and Miscellaneous Solutions), paired with automation instruments (Instruments with 5 products, Centrifuges with 2 products, Incubators with 1 product, Barcoding Systems with 2 products, and Accessories with 5 products). Data management is enabled through connectivity solutions (IH-Com, IH-Web, IH-AᵇID with 4 connectivity products). Quality assurance is supported by Quality Control products (12 products) and the Unity inter-laboratory comparison program. Support services include BRiCare and a dedicated Cybersecurity program. The IH-1000 and IH-500 Systems serve medium to large volume laboratories, while manual and semi-automated options address smaller testing volumes.

Differentiator

Problem solved

Functional benefit

Products and services

• IH-Complete Integrated immunohematology solution combining instruments, reagents, connectivity, support, quality, and cybersecurity for blood transfusion medicine laboratories.
• Blood Typing Reagents Comprehensive range of blood typing and testing reagents including Gel, Tube, and Microplate testing formats covering Blood Grouping ABO/D, Rh/K Phenotyping, Extended Phenotyping, Antibody Screening & Identification, Titration, DAT Testing, Reagent Red Blood Cells, and Miscellaneous Solutions for blood group serology.
• Automation Instruments (IH-1000 and IH-500 Systems) Automated and semi-automated blood typing instruments including the IH-1000 and IH-500 Systems, card readers, centrifuges, incubators, barcoding systems, and accessories for medium to large volume laboratories.
• Connectivity Software (IH-Com, IH-Web, IH-AᵇID) Data management and connectivity solutions including IH-Com, IH-Web, and IH-AᵇID that integrate immunohematology instruments into a seamless system, enabling efficient data evaluation and secure reporting of patient results.
• Unity Quality Control Program Inter-laboratory quality control comparison program and quality control products for blood group serology testing, ensuring the accuracy and validity of clinical test results.
• BRiCare Customer Support Comprehensive technical support and customer service platform providing product support and training resources to the immunohematology community.
• Product Cybersecurity Program Cybersecurity program protecting immunohematology instruments from cyberattacks, ensuring secure and timely reporting of patient results.

Quantifiable outcome

• High sensitivity and specificity in blood typing, enabling identification of very rare blood types and antibodies with greater reliability compared to conventional methods.
• +1 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Healthcare Professionals and Experts (Community Network)coreOthersBio-Rad's IH-Complete solution extends beyond products to include a community network of transfusion science and blood banking experts. Through continued education (Transfusion Science Webinars), training, and product support, Bio-Rad provides a knowledge community that helps healthcare professionals make informed decisions impacting patient lives. This community ecosystem is a core differentiator of the IH-Complete offering.
• Transfusion News and Wiley PublishingminorStrategic or Co-development PartnerBio-Rad partners with Transfusion News and Wiley Publishing to provide educational content and help the immunohematology community stay current in the field of Transfusion Science. This collaboration supports Bio-Rad's educational mission and extends the reach of its scientific content.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Immucor: Immucor is a dedicated transfusion and transplant diagnostics specialist offering blood-typing instruments (Echo, NEO Iris) and a full capture/antibody-screen reagent line — a direct competitor to IH-Complete in hospital blood banks and reference labs.
• Abbott Transfusion Medicine: Abbott's transfusion-medicine business markets the Alinity s and ARCHITECT systems with IH reagents, competing with DiaMed's IH-1000/IH-500 installed base in hospital and reference-laboratory settings.
• QuidelOrtho (Ortho Clinical Diagnostics): QuidelOrtho's Ortho Clinical Diagnostics business is the most direct global competitor to DiaMed/Bio-Rad IH, offering the Ortho Vision analyzer, MTS gel cards, and a full immunohematology reagent portfolio to hospital blood banks and transfusion centers.
• BAG Health Care GmbH: BAG Health Care is a Germany-based immunohematology specialist offering gel-based blood-typing reagents and instruments, competing most directly with DiaMed in Central Europe and shared European accounts.
• Grifols (Diagnostic Division): Grifols' diagnostic division (including Progenika and blood-typing reagents) competes head-to-head with Bio-Rad in immunohematology, particularly in European and blood-center accounts where Grifols has strong positioning.

Broad incumbents

• Roche Diagnostics: Roche Diagnostics is the world leader in clinical chemistry and immunoassay and is a broad incumbent in the integrated hospital diagnostics deals that include IH and LIS components affecting DiaMed's IH-Complete sale.
• Siemens Healthineers: Siemens Healthineers offers a broad clinical diagnostics portfolio (Atellica, ADVIA Centaur) used by the same hospital blood bank and central lab customers, competing for diagnostic budget and connectivity contracts.
• Sunquest Information Systems: Sunquest is an established blood-bank and LIS vendor (Sunquest Mitogen/Sunquest Blood Bank), a competitive neighbor to IH-Com in connectivity and a complementary-or-substitute for DiaMed's data-management offering.
• Beckman Coulter Life Sciences (Danaher): Danaher's Beckman Coulter is a broad incumbent in clinical diagnostics (chemistry, hematology, immunoassay) with adjacent footprint in hospital labs; competes in the same integrated-lab procurement decisions as Bio-Rad IH.

Emerging players

• Quotient Limited: Quotient offers molecular and NGS-based extended blood-typing platforms (e.g., the MosaiQ Extended Antigen Profile), representing an emerging technological alternative to traditional gel/microplate methods used by DiaMed.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/diamed-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DiaMed GmbH